19 June 2013
Keywords: teva, sales, forecast, reach, 3b, israel-based, pharmaceutical
Article | 16 July 2007
Israel-based Teva Pharmaceutical Industries "has a robust corporate strategy that should serve it well for years to come, driving strong
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 July 2007
18 June 2013
© 2013 thepharmaletter.com